COSMO FIRST LIMITED

rs,

FL/SE/2022-23/NOV/05 November 15, 2022 The Manager (Listing) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 Scrip Code: 508814 The Manager (Listing) National Stock Exchange o

64%

label films Unique Proposition ❑ Uniquely positioned with good mix of speciality/Semi Speciality (64% volume FY’22) and commodity films. ❑ Globally among top four players in BOPP ❑World’s largest s

2.5Lakh

reen energy at plants, waste reduction, water treatment etc ❑ Social: Education to 20k+ students, 2.5Lakh lives touched in the fight against COVID-19 ❑ Governance: Strong Independent board with 66% of

66%

2.5Lakh lives touched in the fight against COVID-19 ❑ Governance: Strong Independent board with 66% of Independent Directors Company Overview - Our Businesses Speciality films focused business w

80%

irectors Company Overview - Our Businesses Speciality films focused business with target to sell 80% volume of value add speciality films by FY24 (FY22 64% speciality/semi speciality volume) Three

25%

is D2C, Digital First Omni Channel platform for Pets (Petcare is high growth Industry growing at 25% CAGR) Company Overview - Key Milestones ►Established in 1981, Cosmo Films Ltd.is the pioneer of

16%

les EBITDA EBITDA % PBT PAT EPS* Unaudited Q2 FY 22-23 Unaudited Q1 FY 22-23 Standalone 725 117 16% 93 69 122 Consolidated 778 124 16% 97 73 141 Management Commentary Standalone 791 143 18% 118 8

18%

5 117 16% 93 69 122 Consolidated 778 124 16% 97 73 141 Management Commentary Standalone 791 143 18% 118 88 124 Consolidated 843 150 18% 123 93 150 INR Cr Unaudited Q2 FY 21-22 Standalone 707 12

20%

123 93 150 INR Cr Unaudited Q2 FY 21-22 Standalone 707 128 18% 105 74 97 Consolidated 759 152 20% 128 97 119 ❑ Commissioning of several new production lines in India within a short span coupled wi

32%

pite drop in Q2,FY23 earnings, our financials remain strong with annualized ROCE and ROE at 25% and 32% respectively. Speciality & Semi Speciality Growth and Margins ❑ Expanding Speciality & Semi-Speci

19%

❑ Expanding Speciality & Semi-Speciality films portfolio (high margin category) (FY22 64% volume; 19% CAGR over last 3 years). ❑ Target 80%+ volume from Speciality & Semi Speciality segment by 2024. 1

120%

% CAGR over last 3 years). ❑ Target 80%+ volume from Speciality & Semi Speciality segment by 2024. 120% 100% 80% 60% 40% 20% 0% 38% 43% 52% 64% 62% FY19 57% FY20 48% FY21 36% FY22 69%

“Speciality & Semi Speciality Growth and Margins ❑ Expanding Speciality & Semi-Speciality films portfolio (high margin category) (FY22 64% volume; 19% CAGR over last 3 years).”

“❑ Target 80%+ volume from Speciality & Semi Speciality segment by 2024.”

“❑ A Company with diversified businesses with target 20% CAGR topline growth in next 3 years coupled with commensurate return growth ❑ Potential high Growth Engines include Speciality Films, Speciality Chemicals and a digital first, D2C Petcare business ❑ Speciality Films: ✓ Expanding Speciality portfolio (64% Volume; 18% annual growth in last 3 years).”

“Expansion expected in next one year ✓ Speciality Textile Chemicals – scale up in coming years ✓ Complimentary Adhesive business for Packaging, Lamination and Labels – under commissioning ✓ Target 25%+ ROCE business ❑ Petcare: ✓ Untapped Industry growing @ 25%+ ✓ D2C Digital first Omni-channel presence in Products & Services ✓ Plans to launch about 15 experience centers during FY23 and enhance to 150 experience centers in next a couple of years.”

“✓ Plan to demerge Petcare vertical into separate company in medium term.”

“Capex Project 1 2 3 BOPP Line (World’s Largest Line) CPP Films Line (World’s Largest Line) Value add assets for Specialized BOPET line Total”

“of experience centers during FY23 and enhance online business) What Investors may Expect ?”

“❑ Petcare: Build and demerge the business vertical in medium term to drive shareholders valuation ❑ Going forward B2B segment (speciality films, packaging films, specialized BOPET line, speciality chemicals) and B2C segments (D2C Pet Care and selective Speciality chemicals) will drive growth.”

“✓ Sustainable solutions ❑ Future Pipeline: ✓ Direct Thermal Printable Film (first BOPP film producer to launch) ✓ Sustainable PVC free solutions for graphic applications ✓ Heat reduction films ✓ Shrink Label film ❑ Heat Control Film: ✓ Global Market size US$ 10 billion and expected to grow at 5% CAGR ✓ Increasing demand for films in the building and construction industry is expected to grow of the market.”

“Target 150 experience centers in next a couple of years.”

Three Verticals

1

Films Business

1

Other Businesses

1

Three Verticals

❑Masterbatch (From FY22) ❑Textile Chemicals (From FY22) ❑Adhesive (From H2, FY23) Zigly is D2C, Digital First Omni Channel platform for Pets (Petcare is high growth Industry growing at 25% CAGR) Company Overview - Key Milestones ►Established in 1981, Cosmo Films Ltd.is the pioneer of BOPP Films Industry in India; ►It gradually scaled up the operations accompanied by couple of acquisitions ►3rd and 4th extrusion coating line; ►1st coating line; ►Gas based electricity generation unit ►2012: 2nd coating line ►2013: 9th BOPP line ►2014: 3rd coating line 2012-14 ►2010: 2nd metallizer line ►2011: Korea plant 2010-11 ►2016: CPP line-1 ►2017: 10th BOPP line ►Petcare ►Speciality Chemicals 2022 2016-17 2023 ►Re-branded to Cosmo First Limited ►Specialized BOPET Line 2021 2018-20 ►2018: CPP line-2 ►2020: 6th coating line Masterbatch Line-1 2015 ►4th and 5th coating line; 3rd metallizer line; Upgradation of US plant ►1996: 3rd BOPP line ►2001: 4th BOPP line ►Acquired Gujarat Propack Ltd 2006 1996-0

Films Business

S.No. Capex Project 1 2 3 BOPP Line (World’s Largest Line) CPP Films Line (World’s Largest Line) Value add assets for Specialized BOPET line Total

Other Businesses

Estimated Capex (INR Crs) 350 140 100 590 Annual Capacity (MT) 67,000 25,000 Estimated Commercial Production by H1’FY 2026 H1’FY 2025 End of FY2023 ❑ Specialized Chemicals (scaling up planned during FY23 for capex done in FY22) – Estimated INR 60 Cr Capex in next 3 years. ❑ D2C Pet Care businesses (15 nos. of experience centers during FY23 and enhance online business) What Investors may Expect ? ❑ Flexible Packaging Business: Transformation into primarily Speciality films company with high double digits ROCE ❑ Speciality Chemicals: 10% -15% revenue with 25%+ ROCE in about 5 years. ❑ Petcare: Build and demerge the business vertical in medium term to drive shareholders valuation ❑ Going forward B2B segment (speciality films, packaging films, specialized BOPET line, speciality chemicals) and B2C segments (D2C Pet Care and selective Speciality chemicals) will drive growth. ❑ ESG & Corporate Governance – ESG Initiatives & highest standard for corporate governance in place. CareEdge Research